Peer Review History
| Original SubmissionApril 4, 2024 |
|---|
|
PONE-D-24-12258Factors influencing survival outcomes in patients with stroke in Zimbabwe: A 12-month longitudinal studyPLOS ONE Dear Dr. Kaseke, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please carefully review the comments provided by the reviewers, particularly points raised regarding the inclusion of additional details. Please submit your revised manuscript by Aug 23 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ryan G Wagner, MSc(Med), MBBCh, PhD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met. Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: “Firstly, we would like to acknowledge the participants of the study. Our special thanks and appreciation also goes to the research assistants and staff of the three public referral hospitals; Parirenyatwa, Sally Mugabe and Chitungwiza Central Hospitals in Zimbabwe. We would also want to acknowledge the funders of the study - NIH Fogarty student support grant (Grant Number D43TW009539).” We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “Farayi Kaseke was supported by the Training for Research Excellence and Mentorship in Tuberculosis (TRENT) Program, Grant Number D43TW009539. from the National Institute of Health (NIH) as a PhD scholar. This grant was awarded in collaboration with the University of Zimbabwe Faculty of Medicine. The funding was used for data collection purposes. The funding grant ended on 31st December 2023.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. In the online submission form, you indicated that [Data is available upon request.]. All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. 5. Please include a separate caption for each figure in your manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Overall Introduction The background provides a clear rationale for the study. It might benefit from expanding on why these particular determinants were added (Line 72-73). Methods The study design, data collection, and analysis methods are well-documented. The manuscript addresses the failure of the Cox proportional hazards model and appropriately shifts to the AFT model, which is well-justified. However, it would be helpful to include more information on the validation of the data collection tools and potential sources of bias. Results The results are presented clearly, with appropriate use of tables and figures. The Kaplan-Meier survival curves and Cox-Snell residuals plots effectively illustrate the findings. Discussion The discussion appropriately interprets the results, relating them to existing literature. The limitations section is honest and acknowledges the potential biases and the limited sample size. Future studies could aim for a larger sample size and a longer follow-up period to capture more long-term survival patterns. Specific • Heading - The heading could benefit from being more specific. Consider including that this study was conducted in three tertiary hospitals to provide clearer context. • Abstract - The first hazard ratio (HR) mentioned in the abstract may need to be written out in full, and then subsequent hazard ratios can be abbreviated to maintain clarity. • Sample Size - There was a 27% loss in the sample size. It would be helpful to know if this was accounted for in the initial sample size calculation and its potential impact on the study's statistical power. • Exclusion Criteria (Line 97-96) - Providing a rationale for excluding Transient Ischaemic Attacks (TIA) would strengthen the clarity and justification of the exclusion criteria. • Operational Definitions - Including a definition of stroke would be beneficial. Was the study looking at all types of Stroke or just Ischaemic Strokes? • Data Collection Process - Was the principal investigator present to conduct data quality checks upon collection by the research assistants? Clarifying this would ensure confidence in data integrity. • Variables - Under hospital bill modalities, how does 'Free Service' differ from 'Social Welfare'? - How was the total function of the patients measured? Provide more detail on this measurement to enhance understanding. • Results Table - The results table could benefit from including specific p-values for the important variables to give readers a clearer sense of statistical significance. • Discussion (Line 60-62) - The Thailand study mentions contrasting results, what are the Author’s thoughts on this. Could these differences be due to variations in study design? Expanding on this shows critical evaluation of the paper. • Discussion (Line 67-68) - There are minor spelling errors ("worsen" and "further") that need correction. • Discussion (Line 77) - The statement that higher educational attainment "correlated" with a reduced risk of death needs to be substantiated. The findings indicate that secondary education had a higher survival rate, but the results for primary and tertiary education were not significant in the Gompertz AFT model. Survival status in Table 1 also shows a higher survival status in those with secondary compared to tertiary education. Thus, perhaps reconsideration of the word ‘correlated’ is needed. • Discussion (Line 92-96) - The impact of housing status could be confounded by the presence of a support system. The conclusion stated is about support system, however the data collected is on housing status alone. Clarify whether the study is assessing the effect of having one's own house or the presence of relatives in the house. • Rehabilitation Attendance - The study could benefit from assessing trends in rehabilitation attendance post-discharge. If data on this is available, reporting it would add depth to the findings. • Hospital Payment Modalities - What were the specific p-values for health insurance and social welfare? If these values are between 0.05 and 0.1, it could strengthen your argument that these variables warrant further exploration. • Strengths and Limitations - The statement that recruitment from central hospitals improves generalisability may need reconsideration. Patients at central hospitals are often referred for advanced care, which may not represent the broader population. Overall, the manuscript is a valuable contribution to understanding stroke survival outcomes in low-resource settings. The findings have important implications for healthcare policy and stroke management in Zimbabwe and similar contexts Reviewer #2: Editorial/English language revision required; typos, sentencing and the like needs to be thoroughly revised; please may respect be payed to grammar and spelling. A manuscript of this prospected calibre should be devoid of major errors in language (page 3, line 63/64: "necessitate the need" - this is atrocious English...). The study design: It appears that this paper is a sub-analysis of a "larger" (page 4, 86) study which I don't see referred to in reference or text; was the data collected prospectively? it appears so, but is not explicitly stated. Who identified the patients? How were they recruited? This is crucial to the understanding of the message. Do the respective hospitals have stroke units? The three hospitals were manned by neurologists? (page 4,89). I am not aware that this is the case, never mind weekly outpatient stroke clinics for "all" stroke patients discharged... Page 6 and page 8, the Ethics statement is duplicated. Results: Page 8: The gross discrepancy in mortality between the three hospitals needs to be explored and further explained: is it different populations with different pathologies, different referral pathways or else? Are these all tertiary referral centres, if so why these stark contrasts? Page 9: 86: regarding level of education, only three (3) patients were uneducated (no formal education), all of whom died within the 12 months follow up, obviously making it 100%; this is too small a number to even mention!!! Page 10: Comorbidities: saying that 21 patients had no comorbidities; this is from a clinician's point of view very unlikely and hard to believe. Was HIV status known in the cohort or undetermined or ignored? This would have been very valuable info. The outcomes/survival times according to payer categories don't make sense as the non-paying ones are better off (but these are older pensioners etc.). The privately paying patients had poorer survival, but this may be related to the fact that these were sicker patients with no choice but biting the "private" bill? People in this category will not go to hospital for minor strokes. Patients staying with parents/relatives have better survival because they are probably younger... Here is the crux of the paper and my main criticism which can be allayed by proper/different statistics being applied: The authors seem to find associations by the Gompertz AFT modelling statistics because Cox bivariate regression had failed to show significant correlations between the variables and time outcomes. The authors derive correlations based on the AFT stats, but seem to mix up association and causation: the fact that people living with parents/relatives have better outcomes than people living in their own homes may be related to the fact that the former are younger than the latter... These patients have a better outcomes because their strokes might be milder and they can "afford" to seek hospitalisation for minor strokes as opposed to others. In my view this data set should have been processed by a multivariate regression analysis taking into account the multitude of variables involved in this complex setting of societal and economic factors. The authors make too little and simple reading of what the AFT calculations appear to suggest: there are far too many contradictory outcomes explained too simply as cause and effect. Reviewer #3: Major comments 1. Table 1 does not show p-values of the comparisons between those who survived stroke versus those deceased. 2. There is substantial loss to follow-up. Please kindly provide a Table that compares those who were lost to follow-up versus those who stayed in the study for analysis. 3. Discussion: A sample size of 137 is not a ‘large sample size’ to be reported as a strength of the study. Please remove this statement. 4. Discussion: The authors should please discuss the reasons for the disparity in stroke fatality of 25% in their previous study juxtaposed against 58% in the current study. 5. Adoukounou et al has reported a meta-analysis of stroke fatality in Africa of 33.2%. Authors should please discuss their findings in the light of this meta-analytic data. 6. The use of reference [1] is not correct as this is a Review article. The incidence, prevalence, mortality rates of stroke in Africa have specific studies which should be cited, not the Review article which summarizes these findings. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Andre Mochan Reviewer #3: Yes: FRED STEPHEN SARFO ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-24-12258R1Factors influencing survival outcomes in patients with stroke at three tertiary hospitals in Zimbabwe: A 12-month longitudinal studyPLOS ONE Dear Dr. Kaseke, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 16 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ryan G Wagner, MSc(Med), MBBCh, PhD Academic Editor PLOS ONE Additional Editor Comments: I would ask the authors to carefully review and directly respond to each point raised by the reviewers. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: The authors have addressed a good many of the points raised in the first set of comments. I particularly acknowledge the comment on the exclusion of HIV status data from this paper; please may the authors include this in the text as a point of notice, since HIV status and stroke do have a correlation and Zimbabwe is a high prevalence environment thus HIV is to be considered as a risk factor. My main issue has still not been addressed, yet I do appreciate some of the comments in the authors' response; I copy here directly: The outcomes/survival times according to payer categories don't make sense as the non-paying ones are better off (but these are older pensioners etc.). The privately paying patients had poorer survival, but this may be related to the fact that these were sicker patients with no choice but biting the "private" bill? People in this category will not go to hospital for minor strokes. Patients staying with parents/relatives have better survival because they are probably younger... The inclusion of hospital bill payment modalities is crucial as it sheds light on economic barriers and financial stressors that influence recovery, as discussed in the study introduction & discussion). This is often overlooked, particularly within Zimbabwean contexts, and may similarly pertain to other settings worldwide. Here is the crux of the paper and my main criticism which can be allayed by proper/different statistics being applied: The authors seem to find associations by the Gompertz AFT modelling statistics because Cox bivariate regression had failed to show significant correlations between the variables and time outcomes. The authors derive correlations based on the AFT stats, but seem to mix up association and causation: the fact that people living with parents/relatives have better outcomes than people living in their own homes may be related to the fact that the former are younger than the latter... These patients have a better outcomes because their strokes might be milder and they can "afford" to seek hospitalisation for minor strokes as opposed to others. While I do accept the employment of the Gompertz AFT modelling statistics for the reasons explained by the authors, may some discussion please be devoted to the above. Secondary education is better than primary education, but also better than tertiary education for stroke outcomes? Please may you read through the above comments again and reply accordingly in the manuscript with the arguments raised. Reviewer #3: Authors have addressed all points raised on my initial review except one key issue. Authors should please provide a Table that compares participants who were lost to the follow-up versus those who completed the study versus those who died. For those who were lost, are their demographic, clinical and stroke severity indicators significantly similar or dissimilar to those who completed the study vs those who died? This is an important analysis given the significant attrition reported in your study. Thanks ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Andre Mochan Reviewer #3: Yes: Fred Stephen SARFO ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Factors influencing survival outcomes in patients with stroke at three tertiary hospitals in Zimbabwe: A 12-month longitudinal study PONE-D-24-12258R2 Dear Dr. Kaseke, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ryan G Wagner, MSc(Med), MBBCh, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Andre Mochan ********** |
| Formally Accepted |
|
PONE-D-24-12258R2 PLOS ONE Dear Dr. Kaseke, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Ryan G Wagner Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .